Researchers examine interactions between early life body mass index values and later life lung function.
Enhertu wins two FDA breakthrough therapy designations – Pharmaceutical Technology
The ADC is already approved in different settings for patients with breast cancer, non-small cell lung cancer and gastroesophageal junction adenocarcinoma. Image credit: Shutterstock/Christoph Burgstedt.
August 31, 2023